Your browser doesn't support javascript.
loading
Outcome of malignant lymphoma in Ukraine. Analysis of 563 cases registered in the Ukrainian Lymphoma Registry in 2019-2021.
Stepanishyna, Yana; Manni, Martina; Civallero, Monica; Shokun, Nazar; Skrypets, Tetiana; Burtna, Alevtyna; Shapovalenko, Natalia; Tytorenko, Iryna; Aleksyk, Olena; Pastushenko, Yan; Gubareva, Hanna; Moiseienko, Kateryna; Kadnikova, Tetyana; Rudyuk, Timur; Filonenko, Kateryna; Martynchyk, Arina; Novosad, Olga; Galli, Giulia R; Kryachok, Irina; Federico, Massimo.
Afiliação
  • Stepanishyna Y; Department of Bone Marrow Transplant, National Cancer Institute, Kyiv, Ukraine.
  • Manni M; Department of Hematology, Jules Bordet Institute, Brussels, Belgium.
  • Civallero M; Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia, Modena, Italy.
  • Shokun N; Surgical, Medical and Dental Department of Morphological Sciences related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Skrypets T; Department of Bone Marrow Transplant, National Cancer Institute, Kyiv, Ukraine.
  • Burtna A; Hematology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
  • Shapovalenko N; Department of Bone Marrow Transplant, National Cancer Institute, Kyiv, Ukraine.
  • Tytorenko I; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine.
  • Aleksyk O; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine.
  • Pastushenko Y; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine.
  • Gubareva H; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine.
  • Moiseienko K; Department of medical statistics and national cancer register, National Cancer Institute, Kyiv, Ukraine.
  • Kadnikova T; Department of Bone Marrow Transplant, National Cancer Institute, Kyiv, Ukraine.
  • Rudyuk T; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine.
  • Filonenko K; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine.
  • Martynchyk A; Department of Hematology and Transplantology, University Clinical Center, Gdansk, Poland.
  • Novosad O; Department of Hematology, Austin Health, Melbourne, Australia.
  • Galli GR; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Kryachok I; Department of Biological and Environmental Sciences and Technologies, University of Salento, Lecce, Italy.
  • Federico M; Department of Oncohematology, National Cancer Institute, Kyiv, Ukraine.
Br J Haematol ; 204(5): 1757-1761, 2024 May.
Article em En | MEDLINE | ID: mdl-38400556
ABSTRACT
We report the outcome of 563 cases of newly diagnosed lymphoma registered in 2019-2021, including 176 cases (31.2%) of Hodgkin lymphoma (HL), 130 (23.1%) of diffuse large B-cell lymphoma (DLBCL), 28 (5%) of follicular lymphoma (FL), 16 (2.9%) of mantle cell lymphoma (MCL) and 20 (3.5%) of peripheral T-cell lymphoma (PTCL). After a median follow-up of 30.1 months (95% CI 28.8-31.3), the 3-year overall survival rates were 95%, 83%, 86%, 100%, 61% and 42% for HL, DLBCL, CLL, FL, MCL and PTCL respectively. These data offer valuable information on the curability of lymphoma patients in Ukraine, in a real-world setting.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema de Registros Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Haematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Ucrânia País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sistema de Registros Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Br J Haematol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Ucrânia País de publicação: Reino Unido